TrialEuropean journal of heart failure2025

Efficacy and safety of vutrisiran in transthyretin amyloid cardiomyopathy across the age spectrum: The HELIOS-B trial.

Awais Sheikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.